It has been reported that Novo Nordisk may have inadvertently allowed generics of its GLP-1 agonist semaglutide, the active ingredient in diabetes therapy Ozempic and obesity drug Wegovy, into the ...
In another move designed to reduce the US' reliance on imported medicines, the FDA has launched a pilot of fast-track reviews for generics tested and made in domestic facilities. According to the ...
Creditors are ready to provide debt financing in the amount of 3 billion euros as part of the proposed acquisition of the manufacturer of Zentiva generics. This is reported by foreign media. Earlier, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback